SEC Form 4 · accession 0000884731-16-000018
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manmeet Singh Soni
Officer — EVP, CFO & Treasurer
Period of report
Mar 21, 2016
Accepted (ET)
Mar 22, 2016 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $6.47 | Mar 21, 2016 | A | 550,000 | A | Mar 21, 2017 | Mar 21, 2026 | Common Stock | 550,000 | 550,000 | D |
Explanation of responses
- F1Exercisable as to 25% of the granted shares 137,500 on March 21, 2017 and monthly 11,458 shares beginning on April 21, 2017 and ending on March 21, 2020.
- F2Options expire 10 years from grant date